Photocoagulation Treatment of Proliferative Diabetic Retinopathy: Clinical Application of Diabetic Retinopathy Study (DRS) Findings, DRS Report Number 8
References (7)
Preliminary Report on Effects of Photocoagulation Therapy
Am J Ophthalmol
(1976)Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings
Ophthalmology
(1978)- The Diabetic Retinopathy Study Research Group. Photocoagulation Treatment of Proliferative Diabetic Retinopathy: A...
There are more references available in the full text version of this article.
Cited by (1104)
Endpoints for clinical trials in ophthalmology
2023, Progress in Retinal and Eye ResearchAn insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers
2023, Journal of Controlled ReleaseGeographic variation in diabetic retinopathy screening within the Veterans Health Administration
2023, Primary Care DiabetesChronic ocular small vessel disease: An overview of diabetic retinopathy and its relationship with cardiovascular health
2023, American Heart Journal Plus: Cardiology Research and PracticeTreatment of Proliferative Diabetic Retinopathy in 2023
2024, International Ophthalmology ClinicsSodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database
2024, Diabetes, Obesity and Metabolism
Presented at the Eighty-Fifth Annual Meeting of the American Academy of Ophthalmology, Chicago, November 2–7, 1980.
The DRS is supported by contracts with the National Eye Institute, National Institutes of Health, US Department of Health and Human Services.
Copyright © 1981 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights reserved.